Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial
Osteoporosis International · 2025
DOI: 10.1007/s00198-025-07456-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Osteoporosis International, 2025. Verfasst von Heike A Bischoff-Ferrari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics and Aging Research, University of Zurich, Tièchestrasse 99, 8037, Zurich, Switzerland. Heikea.bischoff-ferrari@uzh.ch. Hauptthemen laut MEDLINE: Cholecalciferol, Osteoporosis, Postmenopausal, Calcifediol, Bone Density Conservation Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: dsm-firmenich AG, University of Zurich.
Abstract (Originalsprache)
Brief rationale: Limited evidence exists on calcifediol's effect on lower extremity function in postmenopausal women with osteoporosis or osteopenia. MAIN RESULT: Calcifediol (20 µg/day) showed no greater benefit than vitamin D3 (3200 IU/day) or placebo. Significance of the paper: Findings do not support high-dose vitamin D3 or calcifediol for improving lower extremity function. PURPOSE: To test the effect of 20 µg/day of calcifediol compared with 3200 IU/day of vitamin D3 and placebo on lower extremity function in postmenopausal women with osteopenia or osteoporosis. METHODS: This is a 3-arm double-blind RCT among postmenopausal women aged 50-70 years with serum 25(OH)D < 30 ng/mL, and a DXA-based diagnosis of osteopenia or osteoporosis. Participants were randomized to receive either daily 20 µg calcifediol, daily 3200 IU vitamin D3, or placebo. The primary endpoint was a composite measure of lower extremity function, assessed at baseline, 3, and 6 months, including four tests: gait speed, knee flexor and extensor strength, and repeated sit-to-stand test. The primary endpoint was the probability of success (improvement or maintenance from baseline) in any of the eight tests, four tests at 3 months and four tests at 6 months. RESULTS: The trial enrolled 152 women (mean age, 61.0 years; mean serum 25(OH)D level, 23.4 ng/mL), and all but one woman completed all follow-up visits. Baseline characteristics, including the four tests of lower extremity function, were balanced across the three groups. The adjusted probability of success in any of the eight tests was 53.6% (95% confidence interval 47%, 60%) with calcifediol, 55.5% (50%, 61%) with vitamin D3, and 61.4% (55%, 67%) with placebo, without significant differences between treatment groups. CONCLUSIONS: Our findings do not support supplementation with daily calcifediol or equivalent high-dose daily vitamin D3 for improving or maintaining lower extremity function among younger postmenopausal women (age 50-70) with osteopenia or osteoporosis, who were pre-selected for vitamin D insufficiency or deficiency (25(OH)D < 30 ng/mL; baseline mean 25(OH)D 23.4 ng/mL). TRIAL REGISTRATION: Clinicaltrials.gov; NCT02527668; https://clinicaltrials.gov/ct2/show/NCT02527668.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics and Aging Research, University of Zurich, Tièchestrasse 99, 8037, Zurich, Switzerland. Heikea.bischoff-ferrari@uzh.ch.
- Centre on Aging and Mobility, University of Zurich, Zurich, Switzerland. Heikea.bischoff-ferrari@uzh.ch.
- Aging Medicine Campus, City Hospital Waid, Zurich, Switzerland. Heikea.bischoff-ferrari@uzh.ch.
- Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center, Boston, MA, USA.
Förderung
- dsm-firmenich AG
- University of Zurich
Zitieren
APA
Bischoff-Ferrari, H. A., Dawson-Hughes, B., Orav, J. E., Ceglia, L., Egli, A., Kistler-Fischbacher, M., Wieczorek, M., & de Godoi Rezende Costa Molino, C. (2025). Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial. Osteoporosis International. https://doi.org/10.1007/s00198-025-07456-7
Vancouver
Bischoff-Ferrari HA, Dawson-Hughes B, Orav JE, Ceglia L, Egli A, Kistler-Fischbacher M, et al. Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial. Osteoporosis International. 2025. doi:10.1007/s00198-025-07456-7
BibTeX
@article{BischoffFerrari2025,
author = {Bischoff-Ferrari, Heike A and Dawson-Hughes, Bess and Orav, John E and Ceglia, Lisa and Egli, Andreas and Kistler-Fischbacher, Melanie and Wieczorek, Maud and de Godoi Rezende Costa Molino, Caroline},
title = {Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial},
journal = {Osteoporosis International},
year = {2025},
doi = {10.1007/s00198-025-07456-7}
}
EUVIMED